Influence of low body weight on long-term clinical outcomes in patients with venous thromboembolism: From the COMMAND VTE registry

Thromb Res. 2021 Feb:198:26-33. doi: 10.1016/j.thromres.2020.11.022. Epub 2020 Nov 25.

Abstract

Introduction: There is a paucity of data on the influence of low body weight on clinical outcomes in patients with acute venous thromboembolism (VTE).

Materials and methods: The COMMAND VTE registry is a multicenter cohort study enrolling 3027 consecutive patients with acute symptomatic VTE. The current study population consisted of 2778 patients with available body weight value, who were divided into 2 groups; 1705 patients with lower body weight (≤60 kg) and 1073 patients with higher body weight (>60 kg).

Results: Patients with lower body weight were older (70.8 versus 60.9 years, P < 0.001), and more often women (75% versus 38%, P < 0.001), and more often had active cancer (27% versus 19%, P < 0.001) than those with higher body weight. The cumulative 5-year incidence of recurrent VTE was not significantly different between the 2 groups (10.6% versus 10.7%, P = 0.51). The cumulative 5-year incidences of major bleeding and all-cause death were significantly higher in patients with lower body weight than in those with higher body weight (14.6% versus 9.6%, P < 0.001, and 35.8% versus 19.8%, P < 0.001, respectively). The excess adjusted risk of patients with lower body weight relative to those with higher body weight remained significant for major bleeding and all-cause death (HR 1.57, 95%CI: 1.16-2.12, P = 0.003, and HR 1.50, 95%CI: 1.24-1.81, P < 0.001, respectively).

Conclusions: In the current Japanese real-world registry, there were a high proportion of patients with low body weight, who had a higher risk for major bleeding and mortality without significant excess risk for recurrent VTE.

Keywords: Bleeding; Low body weight; Mortality; Outcome; Recurrence; Venous thromboembolism.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants
  • Body Weight
  • Cohort Studies
  • Female
  • Hemorrhage / etiology
  • Humans
  • Recurrence
  • Registries
  • Venous Thromboembolism* / epidemiology

Substances

  • Anticoagulants